Hyliion (NYSE:HYLN) Downgraded by Wall Street Zen to Sell

Key Points

• Hyliion's stock rating has been downgraded from "hold" to "sell" by analysts at Wall Street Zen, raising concerns among investors.
• Despite the downgrade, Zacks Research has upgraded its rating from "strong sell" to "hold," indicating mixed analyst sentiments.
• Insider trading activity showed Director Richard Joseph Freeland increased his stake by 41.19% after purchasing 65,000 shares of the company at $1.57 per share.

Hyliion (NYSE:HYLN - Get Free Report) was downgraded by equities research analysts at Wall Street Zen from a "hold" rating to a "sell" rating in a note issued to investors on Sunday.

Separately, Zacks Research raised shares of Hyliion from a "strong sell" rating to a "hold" rating in a research report on Wednesday, August 13th. Two research analysts have rated the stock with a Hold rating, Based on data from MarketBeat, Hyliion has an average rating of "Hold".

Hyliion Trading Down 2.3%

Shares of NYSE:HYLN traded down $0.04 during trading on Friday, reaching $1.68. The company's stock had a trading volume of 751,817 shares, compared to its average volume of 1,348,521. Hyliion has a 12 month low of $1.11 and a 12 month high of $4.10. The stock has a market capitalization of $294.73 million, a PE ratio of -4.54 and a beta of 2.73. The firm's 50 day simple moving average is $1.55 and its two-hundred day simple moving average is $1.54.

Insider Transactions at Hyliion

In other Hyliion news, Director Richard Joseph Freeland acquired 65,000 shares of the business's stock in a transaction that occurred on Thursday, August 21st. The shares were bought at an average cost of $1.57 per share, with a total value of $102,050.00. Following the completion of the acquisition, the director directly owned 222,798 shares in the company, valued at $349,792.86. This represents a 41.19% increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 20.90% of the stock is currently owned by insiders.

Hedge Funds Weigh In On Hyliion

Several institutional investors have recently bought and sold shares of HYLN. JPMorgan Chase & Co. increased its holdings in Hyliion by 405.6% during the fourth quarter. JPMorgan Chase & Co. now owns 321,008 shares of the company's stock valued at $838,000 after buying an additional 257,514 shares during the period. Wells Fargo & Company MN boosted its stake in Hyliion by 35.7% in the fourth quarter. Wells Fargo & Company MN now owns 93,123 shares of the company's stock valued at $243,000 after acquiring an additional 24,474 shares in the last quarter. Raymond James Financial Inc. acquired a new stake in Hyliion in the fourth quarter valued at approximately $43,000. Barclays PLC boosted its stake in Hyliion by 13.6% in the fourth quarter. Barclays PLC now owns 209,806 shares of the company's stock valued at $547,000 after acquiring an additional 25,121 shares in the last quarter. Finally, Dimensional Fund Advisors LP boosted its stake in Hyliion by 628.8% in the fourth quarter. Dimensional Fund Advisors LP now owns 513,927 shares of the company's stock valued at $1,335,000 after acquiring an additional 443,412 shares in the last quarter. 22.81% of the stock is owned by hedge funds and other institutional investors.

Hyliion Company Profile